Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Research and Treatment|June 12, 2025
Programmed Death-Ligand 1 Expression Across Multiple Assays in Ovarian Cancer: A Comparative AnalysisEun Bi Jang, Kyeong A So, Wook Youn Kim, et al.Journal of Pathology and Translational Medicine|October 14, 2015
Chronic Placental Inflammation in Twin PregnanciesHeejin Bang, Go Eun Bae, Ha Young Park, et al.Diagnostics (Basel, Switzerland)|February 25, 2022
Automated Diagnosis of Cervical Intraepithelial Neoplasia in Histology Images via Deep LearningBum-Joo Cho, Jeong-Won Kim, Jungkap Park, et al.Annals of Diagnostic Pathology|December 1, 2019
Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendationsHeejin Bang, Heejung Park, Sanghui Park, et al.Translational Oncology|May 15, 2017
Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2-Amplified Gastric Cancer Patient-Derived Cell ModelJiryeon Jang, Hee Kyung Kim, Heejin Bang, et al.Oncogene|December 8, 2020
Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signalingJun Lu, Heejin Bang, Su Mi Kim, et al.Molecular Cancer Therapeutics|February 28, 2018
MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal CarcinomatosisHee Kyung Kim, InKyoung Lee, Heejin Bang, et al.Oncotarget|January 12, 2017
Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instabilityJunhun Cho, Jeeyun Lee, Heejin Bang, et al.Scientific Reports|December 6, 2016
c-MET as a Potential Therapeutic Target in Ovarian Clear Cell CarcinomaHa-Jeong Kim, Aera Yoon, Ji-Yoon Ryu, et al.Oncotarget|January 26, 2017
Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusionSun Young Kim, Taejin Ahn, Heejin Bang, et al.Pageof 3